In HCC cells, RUNX1-IT1 modulated the WNT/-catenin pathway by directly binding to miR-632 and acting as ceRNA to promote the expression of the miR-632 target gene, GSK-3 [128]. The gene discussed is RUNX1; the disease is hepatocellular carcinoma.